Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

A NEW CLASS OF “INJECTABLES” TO ENTER ITALY’S ORTHOPAEDIC MARKET THANKS TO A DYNAMIC PARTNERSHIP WITH MEDICAL MANUFACTURERS CONTURA ORTHOPAEDICS

Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection, approved in Europe to treat knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing OA, which affects around 8,6 million people in Italy1…current treatments are not long-lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of OA treatments on offer to help patients – until now.

Hyaluronic Acid: A Promising Path for Managing Knee Osteoarthritis and Supporting Cartilage Health

Discover how hyaluronic acid injections are transforming knee osteoarthritis care. This innovative treatment not only relieves pain and improves joint mobility but also helps protect and potentially repair cartilage. Unlike traditional pain management therapies, hyaluronic acid restores the joint’s natural lubrication and cushioning, offering safe and lasting relief for people with osteoarthritis. Clinical research highlights low risk of side effects and sustained benefits, making hyaluronic acid a vital option for managing knee OA and delaying invasive surgery. Learn why hyaluronic acid is becoming a key player in the future of osteoarthritis treatment.

Read More »

Methotrexate in Knee Osteoarthritis: Balancing Hope with Practical Challenges

Methotrexate, a medication traditionally used for rheumatoid arthritis, is being explored as a treatment for knee osteoarthritis due to its inflammation-reducing properties. This article explains how methotrexate works, summarizes research on its effectiveness and safety for knee osteoarthritis, and discusses dosing challenges and side effects such as nausea and liver changes. Early studies suggest the drug may relieve symptoms and protect joint cartilage, but personalized dosing and regular monitoring are crucial to manage risks. Ongoing research and clinical trials are needed to clarify methotrexate’s long-term role in osteoarthritis care, highlighting the importance of balancing innovation with patient safety.

Read More »